U 995Alternative Names: Shark cartilage-derived angiogenesis inhibitor - Gwo-Chang GMP Pharmaceutical Co.
Latest Information Update: 28 Aug 2002
Price : *
At a glance
- Originator Gwo-Chyang GMP Pharmaceutical
- Class Antineoplastics; Dipeptides
- Mechanism of Action Angiogenesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Mar 1999 New profile
- 10 Mar 1999 Preclinical development for Cancer in Taiwan (Unknown route)